Header Logo

Connection

SUSAN BLANEY to DNA Adducts

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about DNA Adducts.
SUSAN BLANEY
Connection Strength
0.012
DNA Adducts
  1. Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors. Clin Cancer Res. 2003 Feb; 9(2):703-10.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.